The Dutch infrastructure for cancer-specific ATMP Research (DARE-NL) is a unique partnership between all academic developers of Advanced Therapy Medicinal Products (ATMPs) in the Netherlands. ATMPs are the next revolution in medicine promising a leap in survival, quality of life and cure for cancer patients. Although many novel ATMPs are under development in academic centers, the steps toward market approval and clinical application are complex and do not fit the traditional frameworks. The overarching goal of DARE-NL is to accelerate clinical testing of novel ATMPs for cancer patients to ensure timely and sustainable access to potentially curative treatment options for cancer patients.
Click here for more information